How Disease Surveillance Will Help Spot Disease X
Picodya has developed a scalable solution that is being used by the NIH to find Disease X and stop the next pandemic in its tracks.
Read MorePosted by Chris Wolski | Feb 1, 2024 | Emerging & Zoonotic Diseases |
Picodya has developed a scalable solution that is being used by the NIH to find Disease X and stop the next pandemic in its tracks.
Read MorePosted by Andy Lundin | Jan 17, 2024 | Covid 19 |
Using a molecule found in crustaceans, researchers developed a rapid approach that detects COVID comparably to one used in vaccine research.
Read MorePosted by Chris Wolski | Jan 17, 2024 | Sexually Transmitted Diseases |
Emphasizing the healthcare disparities through increased testing for effective prevention of congenital syphilis needs addressing.
Read MorePosted by Andy Lundin | Jan 16, 2024 | Melanoma, Molecular Diagnostics |
The molecular Skin Fluorescence Imaging System noninvasively identifies and assesses activity associated with melanoma development.
Read MorePosted by Andy Lundin | Jan 9, 2024 | Point-of-Care, Sexually Transmitted Diseases |
NOWDiagnostics submitted a De Novo Classification Request to the U.S. FDA for the company’s First to Know at-home syphilis test.
Read More